More Imugene Ltd news Imugene LtdASX: IMU First patient IV dosed in VAXINIA Phase 1 clinical trial Sep 21, 2022 at 3:50 AM UTC · Issued by Imugene Ltd As issuedPlain English Imugene Ltd has released a press release. View Attachment
